Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement

Adherium Limited

Development, manufacture and supply of its Hailie digital health technologies which address sub-optimal medication use and improve health outcomes in chronic disease.

ADR$0.013
 -0.001 -7.14%

Data last updated:Sep 20, 2024 – 3.41pm. Data is 20 mins delayed.

Previous Close

0.014

Open

0.013

Day Range

0.013 - 0.013

52 Week Range

0.011 - 0.089

Volume

9,632

Value

125

Bid

0.013

Ask

0.014

Dividend Yield

0.00%

P/E Ratio

0.00

Market Cap

9.862M

Total Issue

758,579,962

ASX Announcements

Update - Notification of cessation of securities - ADR

Appendix 3H (Notification of cessation of securities)

  • Aug 30, 2024
  • 4 pages

Market Sensitive

Preliminary Final Report

Preliminary Final Report

  • Aug 29, 2024
  • 12 pages

Market Sensitive

Quarterly Activities/Appendix 4C Cash Flow Report

CTE – Fourth Quarter Cashflow Report, CTE - Fourth Quarter Activity Report

  • Jul 30, 2024
  • 9 pages

Ceasing to be a substantial holder

Ceasing to be a substantial holder

  • Jul 25, 2024
  • 8 pages

Notification of cessation of securities - ADR

Appendix 3H (Notification of cessation of securities)

  • Jul 10, 2024
  • 4 pages

View all ADR announcements

TODAY

No stories for Adherium Limited are available.

Search afr.com for Adherium Limited stories

Copyright © 2024. Company information displayed on The Australian Financial Review is sourced from Morningstar and ASX and is subject to their terms and conditions as set out in our Terms of Use. The Australian Financial Review does not accept any responsibility for the accuracy and/or completeness of such data or information.